• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于对功能性致病种系变体进行分类的深度学习算法的真实世界评估。

Real-world evaluation of deep learning algorithms to classify functional pathogenic germline variants.

作者信息

Chow Ryan D, Parikh Ravi B, Nathanson Katherine L

机构信息

Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Division of Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

medRxiv. 2024 Apr 7:2024.04.05.24305402. doi: 10.1101/2024.04.05.24305402.

DOI:10.1101/2024.04.05.24305402
PMID:38633773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11023677/
Abstract

Deep learning models for variant pathogenicity prediction can recapitulate expert-curated annotations, but their performance remains unexplored on actual disease phenotypes in a real-world setting. Here, we apply three state-of-the-art pathogenicity prediction models to classify hereditary breast cancer gene variants in the UK Biobank. Predicted pathogenic variants in , and , but not and were associated with increased breast cancer risk. We explored gene-specific score thresholds for variant pathogenicity, finding that they could improve model performance. However, when specifically tasked with classifying variants of uncertain significance, the deep learning models were generally of limited clinical utility.

摘要

用于变异致病性预测的深度学习模型可以概括专家整理的注释,但其在实际疾病表型的真实环境中的性能仍未得到探索。在这里,我们应用三种最先进的致病性预测模型对英国生物银行中的遗传性乳腺癌基因变异进行分类。预测的 、 和 中的致病性变异,但 和 中的变异与乳腺癌风险增加无关。我们探索了变异致病性的基因特异性评分阈值,发现它们可以提高模型性能。然而,当专门用于对意义不明确的变异进行分类时,深度学习模型的临床效用通常有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004c/11023677/e64c22200fda/nihpp-2024.04.05.24305402v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004c/11023677/08ad54b26cbe/nihpp-2024.04.05.24305402v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004c/11023677/451cf4a32468/nihpp-2024.04.05.24305402v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004c/11023677/e64c22200fda/nihpp-2024.04.05.24305402v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004c/11023677/08ad54b26cbe/nihpp-2024.04.05.24305402v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004c/11023677/451cf4a32468/nihpp-2024.04.05.24305402v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004c/11023677/e64c22200fda/nihpp-2024.04.05.24305402v1-f0003.jpg

相似文献

1
Real-world evaluation of deep learning algorithms to classify functional pathogenic germline variants.用于对功能性致病种系变体进行分类的深度学习算法的真实世界评估。
medRxiv. 2024 Apr 7:2024.04.05.24305402. doi: 10.1101/2024.04.05.24305402.
2
Phenotypic evaluation of deep learning models for classifying germline variant pathogenicity.用于分类种系变异致病性的深度学习模型的表型评估。
NPJ Precis Oncol. 2024 Oct 19;8(1):235. doi: 10.1038/s41698-024-00710-x.
3
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.在高危芬兰 BRCA1/2 种系突变阴性的乳腺癌和/或卵巢癌个体中筛查 BRCA1、BRCA2、CHEK2、PALB2、BRIP1、RAD50 和 CDH1 突变。
Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.
4
Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.多基因风险评分与携带高风险和中风险乳腺癌基因的女性乳腺癌的相关性研究。
JAMA Netw Open. 2020 Jul 1;3(7):e208501. doi: 10.1001/jamanetworkopen.2020.8501.
5
Gene-specific machine learning model to predict the pathogenicity of variants.用于预测变异致病性的基因特异性机器学习模型。
Front Genet. 2022 Sep 30;13:982930. doi: 10.3389/fgene.2022.982930. eCollection 2022.
6
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.全基因组测序揭示了家族性乳腺癌发病机制中的临床相关见解。
Ann Oncol. 2019 Jul 1;30(7):1071-1079. doi: 10.1093/annonc/mdz132.
7
Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.女性 BRCA1/2、PALB2、CHEK2 和 ATM 携带者的癌症风险管理。
Breast Cancer Res Treat. 2020 Jul;182(2):421-428. doi: 10.1007/s10549-020-05699-y. Epub 2020 May 22.
8
Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients.利用共分离和杂合性缺失分析来确定遗传性乳腺癌患者未分类变异的致病性。
Front Oncol. 2020 Oct 2;10:571330. doi: 10.3389/fonc.2020.571330. eCollection 2020.
9
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.在乳腺癌先证者中检测到的两个错义变体可阻止BRCA2与PALB2蛋白相互作用。
Front Oncol. 2018 Oct 25;8:480. doi: 10.3389/fonc.2018.00480. eCollection 2018.
10
Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients.BRCA1/2 阴性的巴西患者中常见中等至高风险遗传性乳腺癌和卵巢癌易感基因种系变异。
Breast Cancer Res Treat. 2021 Feb;185(3):851-861. doi: 10.1007/s10549-020-05985-9. Epub 2020 Oct 30.

本文引用的文献

1
Accurate proteome-wide missense variant effect prediction with AlphaMissense.使用 AlphaMissense 进行精确的全蛋白质错义变异效应预测。
Science. 2023 Sep 22;381(6664):eadg7492. doi: 10.1126/science.adg7492.
2
Genome-wide prediction of disease variant effects with a deep protein language model.利用深度蛋白质语言模型进行全基因组疾病变异效应预测。
Nat Genet. 2023 Sep;55(9):1512-1522. doi: 10.1038/s41588-023-01465-0. Epub 2023 Aug 10.
3
Disease variant prediction with deep generative models of evolutionary data.利用进化数据的深度生成模型进行疾病变异预测。
Nature. 2021 Nov;599(7883):91-95. doi: 10.1038/s41586-021-04043-8. Epub 2021 Oct 27.
4
Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank.通过对英国生物库的外显子组测序推进人类遗传学研究和药物发现。
Nat Genet. 2021 Jul;53(7):942-948. doi: 10.1038/s41588-021-00885-0. Epub 2021 Jun 28.
5
Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.遗传性癌症中意义不明的变异个体的临床管理:系统评价和荟萃分析。
Clin Genet. 2021 Aug;100(2):119-131. doi: 10.1111/cge.13966. Epub 2021 Apr 21.
6
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.乳腺癌风险基因 - 超过 113000 名女性的关联分析。
N Engl J Med. 2021 Feb 4;384(5):428-439. doi: 10.1056/NEJMoa1913948. Epub 2021 Jan 20.
7
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.遗传/家族性高风险评估:乳腺癌、卵巢癌和胰腺癌,第 2.2021 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
8
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
9
The UK Biobank resource with deep phenotyping and genomic data.英国生物银行资源库,具有深度表型和基因组数据。
Nature. 2018 Oct;562(7726):203-209. doi: 10.1038/s41586-018-0579-z. Epub 2018 Oct 10.
10
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.英国生物银行:一个用于识别多种中老年复杂疾病病因的开放获取资源。
PLoS Med. 2015 Mar 31;12(3):e1001779. doi: 10.1371/journal.pmed.1001779. eCollection 2015 Mar.